Phase 1 public comments now available!
Phase 1 of Rethinking the Guidelines closed on October 31, 2016. Visit the Rethinking the Guidelines section to view the submissions we received.
Timelines for Phase 2 of Rethinking the Guidelines will be announced at a later date. For more information, please visit the Rethinking the Guidelines section or contact us at the following coordinates:
Patented Medicine Prices Review Board
(Rethinking the Guidelines)
Box L40, 333 Laurier Avenue West, Suite 1400
Ottawa, Ontario K1P 1C1
Follow us on Twitter @PMPRB_CEPMB and at the hashtag #RethinkingtheGuidelines for updates and additional announcements.